Compounded Tirzepatide in Wilmington, DE — Telehealth Access from $125/mo

Compounded tirzepatide is prepared by a licensed 503A pharmacy for an individual prescription. Branded Zepbound is an FDA-approved finished product with a full FDA review of safety, efficacy, and manufacturing. Compounded versions are not FDA-approved, not generic equivalents, and are prescribed only when a licensed clinician determines they are appropriate for your history.

Ozari publishes flat-rate plans for Wilmington, Delaware: $125/month equivalent on the 3-Month Starter Plan ($375 every 3 months, first-time GLP-1 users), $199/month on Quarterly ($597 every 3 months), or $235/month month-to-month. Free shipping is included; no insurance is required.

Safety depends on appropriate prescribing, pharmacy standards, and follow-up care — not price alone. Ozari uses named 503A partners (Hallandale Pharmacy, PCAB-accredited; VialsRx, USP 797) and a LegitScript-certified telehealth platform. Compounded products are still not FDA-approved finished drugs, so your clinician must review contraindications before treatment.

You complete a secure online intake, a licensed clinician reviews your record, and a prescription is sent to a 503A partner pharmacy only if treatment is medically appropriate. Medication ships to your Wilmington, Delaware address. There is no checkout without clinician review.

In SURMOUNT-1 (NEJM 2022), FDA-approved tirzepatide 15 mg with lifestyle support produced a mean 20.9% body weight reduction at 72 weeks versus 3.1% with placebo. Published trial averages are not guarantees for compounded products or for any individual patient.

Delaware requires health insurers to cover telehealth services on par with in-person care, and the state has adopted Medicaid telehealth expansion policies that extend to weight management consultations. The Delaware Medical Practice Act permits physicians to establish patient relationships via synchronous video, making it fully legal for Ozari-affiliated physicians to prescribe compounded medications to Delaware residents without a prior in-person visit.

Ozari routes prescriptions to Hallandale Pharmacy (PCAB-accredited 503A, Fort Lauderdale, FL) or VialsRx (U.S.-licensed 503A, USP 797). Your vial label and patient materials identify the dispensing pharmacy for that shipment.

Yes. Eligible Wilmington, Delaware patients receive free expedited shipping to residential or business addresses statewide once a prescription is approved and filled. Cold-chain packaging is used when required for medication stability in transit.